Vitamin D status and supplementation before and after Bariatric Surgery : Recommendations based on a systematic review and meta-analysis
© 2023. The Author(s)..
Bariatric surgery is associated with a postoperative reduction of 25(OH) vitamin D levels (25(OH)D) and with skeletal complications. Currently, guidelines for 25(OH)D assessment and vitamin D supplementation in bariatric patients, pre- and post-surgery, are still lacking. The aim of this work is to analyse systematically the published experience on 25(OH)D status and vitamin D supplementation, pre- and post-surgery, and to propose, on this basis, recommendations for management. Preoperatively, 18 studies including 2,869 patients were evaluated. Prevalence of vitamin D insufficiency as defined by 25(OH)D < 30 ng/mL (75 nmol/L) was 85%, whereas when defined by 25(OH)D < 20 ng/mL (50 nmol/L) was 57%. The median preoperative 25(OH)D level was 19.75 ng/mL. After surgery, 39 studies including 5,296 patients were analysed and among those undergoing either malabsorptive or restrictive procedures, a lower rate of vitamin D insufficiency and higher 25(OH)D levels postoperatively were observed in patients treated with high-dose oral vitamin D supplementation, defined as ≥ 2,000 IU/daily (mostly D3-formulation), compared with low-doses (< 2,000 IU/daily). Our recommendations based on this systematic review and meta-analysis should help clinical practice in the assessment and management of vitamin D status before and after bariatric surgery. Assessment of vitamin D should be performed pre- and postoperatively in all patients undergoing bariatric surgery. Regardless of the type of procedure, high-dose supplementation is recommended in patients after bariatric surgery.
Errataetall: |
ErratumIn: Rev Endocr Metab Disord. 2024 Apr;25(2):447-448. - PMID 38502455 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
Reviews in endocrine & metabolic disorders - 24(2023), 6 vom: 12. Dez., Seite 1011-1029 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Giustina, Andrea [VerfasserIn] |
---|
Links: |
---|
Themen: |
1406-16-2 |
---|
Anmerkungen: |
Date Completed 06.12.2023 Date Revised 23.03.2024 published: Print-Electronic ErratumIn: Rev Endocr Metab Disord. 2024 Apr;25(2):447-448. - PMID 38502455 Citation Status MEDLINE |
---|
doi: |
10.1007/s11154-023-09831-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361631995 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM361631995 | ||
003 | DE-627 | ||
005 | 20240323234641.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11154-023-09831-3 |2 doi | |
028 | 5 | 2 | |a pubmed24n1342.xml |
035 | |a (DE-627)NLM361631995 | ||
035 | |a (NLM)37665480 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Giustina, Andrea |e verfasserin |4 aut | |
245 | 1 | 0 | |a Vitamin D status and supplementation before and after Bariatric Surgery |b Recommendations based on a systematic review and meta-analysis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.12.2023 | ||
500 | |a Date Revised 23.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a ErratumIn: Rev Endocr Metab Disord. 2024 Apr;25(2):447-448. - PMID 38502455 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s). | ||
520 | |a Bariatric surgery is associated with a postoperative reduction of 25(OH) vitamin D levels (25(OH)D) and with skeletal complications. Currently, guidelines for 25(OH)D assessment and vitamin D supplementation in bariatric patients, pre- and post-surgery, are still lacking. The aim of this work is to analyse systematically the published experience on 25(OH)D status and vitamin D supplementation, pre- and post-surgery, and to propose, on this basis, recommendations for management. Preoperatively, 18 studies including 2,869 patients were evaluated. Prevalence of vitamin D insufficiency as defined by 25(OH)D < 30 ng/mL (75 nmol/L) was 85%, whereas when defined by 25(OH)D < 20 ng/mL (50 nmol/L) was 57%. The median preoperative 25(OH)D level was 19.75 ng/mL. After surgery, 39 studies including 5,296 patients were analysed and among those undergoing either malabsorptive or restrictive procedures, a lower rate of vitamin D insufficiency and higher 25(OH)D levels postoperatively were observed in patients treated with high-dose oral vitamin D supplementation, defined as ≥ 2,000 IU/daily (mostly D3-formulation), compared with low-doses (< 2,000 IU/daily). Our recommendations based on this systematic review and meta-analysis should help clinical practice in the assessment and management of vitamin D status before and after bariatric surgery. Assessment of vitamin D should be performed pre- and postoperatively in all patients undergoing bariatric surgery. Regardless of the type of procedure, high-dose supplementation is recommended in patients after bariatric surgery | ||
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Bariatric surgery | |
650 | 4 | |a Obesity | |
650 | 4 | |a Vitamin D assay | |
650 | 4 | |a Vitamin D insufficiency | |
650 | 4 | |a Vitamin D supplementation | |
650 | 7 | |a Vitamin D |2 NLM | |
650 | 7 | |a 1406-16-2 |2 NLM | |
650 | 7 | |a Vitamins |2 NLM | |
700 | 1 | |a di Filippo, Luigi |e verfasserin |4 aut | |
700 | 1 | |a Facciorusso, Antonio |e verfasserin |4 aut | |
700 | 1 | |a Adler, Robert A |e verfasserin |4 aut | |
700 | 1 | |a Binkley, Neil |e verfasserin |4 aut | |
700 | 1 | |a Bollerslev, Jens |e verfasserin |4 aut | |
700 | 1 | |a Bouillon, Roger |e verfasserin |4 aut | |
700 | 1 | |a Casanueva, Felipe F |e verfasserin |4 aut | |
700 | 1 | |a Cavestro, Giulia Martina |e verfasserin |4 aut | |
700 | 1 | |a Chakhtoura, Marlene |e verfasserin |4 aut | |
700 | 1 | |a Conte, Caterina |e verfasserin |4 aut | |
700 | 1 | |a Donini, Lorenzo M |e verfasserin |4 aut | |
700 | 1 | |a Ebeling, Peter R |e verfasserin |4 aut | |
700 | 1 | |a Fassio, Angelo |e verfasserin |4 aut | |
700 | 1 | |a Frara, Stefano |e verfasserin |4 aut | |
700 | 1 | |a Gagnon, Claudia |e verfasserin |4 aut | |
700 | 1 | |a Latella, Giovanni |e verfasserin |4 aut | |
700 | 1 | |a Marcocci, Claudio |e verfasserin |4 aut | |
700 | 1 | |a Mechanick, Jeffrey I |e verfasserin |4 aut | |
700 | 1 | |a Minisola, Salvatore |e verfasserin |4 aut | |
700 | 1 | |a Rizzoli, René |e verfasserin |4 aut | |
700 | 1 | |a Santini, Ferruccio |e verfasserin |4 aut | |
700 | 1 | |a Shaker, Joseph L |e verfasserin |4 aut | |
700 | 1 | |a Sempos, Christopher |e verfasserin |4 aut | |
700 | 1 | |a Ulivieri, Fabio Massimo |e verfasserin |4 aut | |
700 | 1 | |a Virtanen, Jyrki K |e verfasserin |4 aut | |
700 | 1 | |a Napoli, Nicola |e verfasserin |4 aut | |
700 | 1 | |a Schafer, Anne L |e verfasserin |4 aut | |
700 | 1 | |a Bilezikian, John P |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Reviews in endocrine & metabolic disorders |d 2000 |g 24(2023), 6 vom: 12. Dez., Seite 1011-1029 |w (DE-627)NLM115974520 |x 1573-2606 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2023 |g number:6 |g day:12 |g month:12 |g pages:1011-1029 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11154-023-09831-3 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2023 |e 6 |b 12 |c 12 |h 1011-1029 |